FY23 EPS consensus $5.68. Narrows FY23 revenue view to $1.255B-$1.27B from $1.245B-$1.27B, consensus $1.26B.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LNTH:
- Lantheus Reports Third Quarter 2023 Financial Results
- Lantheus price target lowered to $100 from $110 at Truist
- William Blair biotech analyst to hold an analyst/industry conference call
- Lantheus program validated by Point Biopharma buyout, says Mizuho
- Eli Lilly deal for Point puts radiopharma names in spotlight